WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build
WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build
WHO Antenatal Care Guideline Implementation Guide, published by World Health Organization (WHO). This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/costateixeira/smart-anc/ and changes regularly. See the Directory of published versions
| Active as of 2021-06-11 |
<PlanDefinition xmlns="http://hl7.org/fhir">
<id value="ANCDT10"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<table class="grid dict">
<tr>
<th scope="row"><b>Id: </b></th>
<td style="padding-left: 4px;">ANCDT10</td>
</tr>
<tr>
<th scope="row"><b>Url: </b></th>
<td style="padding-left: 4px;"><a href="PlanDefinition-ANCDT10.html">ANC.DT.10 Hepatitis C testing</a></td>
</tr>
<tr>
<th scope="row"><b>Version: </b></th>
<td style="padding-left: 4px;">0.3.0</td>
</tr>
<tr>
<th scope="row"><b>Identifier: </b></th>
<td style="padding-left: 4px;">
<p style="margin-bottom: 5px;">
<b>value: </b> <span>ANC.DT.10</span>
</p>
</td>
</tr>
<tr>
<th scope="row"><b>Name: </b></th>
<td style="padding-left: 4px;">ANCDT10</td>
</tr>
<tr>
<th scope="row"><b>Title: </b></th>
<td style="padding-left: 4px;">ANC.DT.10 Hepatitis C testing</td>
</tr>
<tr>
<th scope="row"><b>Status: </b></th>
<td style="padding-left: 4px;">active</td>
</tr>
<tr>
<th scope="row"><b>Experimental: </b></th>
<td style="padding-left: 4px;">false</td>
</tr>
<tr>
<th scope="row"><b>Type: </b></th>
<td style="padding-left: 4px;">
<p style="margin-bottom: 5px;">
<b>system: </b> <span><a href="http://hl7.org/fhir/R4/codesystem-plan-definition-type.html">http://terminology.hl7.org/CodeSystem/plan-definition-type</a></span>
</p>
<p style="margin-bottom: 5px;">
<b>code: </b> <span>eca-rule</span>
</p>
</td>
</tr>
<tr>
<th scope="row"><b>Date: </b></th>
<td style="padding-left: 4px;">2021-06-11 23:02:59-0600</td>
</tr>
<tr>
<th scope="row"><b>Publisher: </b></th>
<td style="padding-left: 4px;">World Health Organization (WHO)</td>
</tr>
<tr>
<th scope="row"><b>Description: </b></th>
<td style="padding-left: 4px;">Depending on the population prevalence, and woman's medical history, conduct hepatitis C testing</td>
</tr>
<tr>
<th scope="row"><b>Use Context: </b></th>
<td style="padding-left: 4px;">
<table class="grid-dict">
<tr><th><b>code</b></th><th><b>value</b></th><th><b>display</b></th></tr>
<tr>
<td>task</td>
<td>ANC.B9.</td>
<td>Conduct laboratory tests and imaging</td>
</tr>
</table>
</td>
</tr>
<tr>
<th scope="row"><b>Jurisdiction: </b></th>
<td style="padding-left: 4px;">001</td>
</tr>
<tr>
<th scope="row"><b>Libraries: </b></th>
<td style="padding-left: 4px;">
<table class="grid-dict">
<tr><td><a href="Library-ANCDT10.html">ANC.DT.10 Hepatitis C testing</a></td></tr>
</table>
</td>
</tr>
<tr>
<th scope="row"><b>Actions: </b></th>
<td style="padding-left: 4px;">
<table class="grid-dict">
<tr>
<td>
<b> ANC.DT.10 Hepatitis C testing:</b> <br/>
<b>When:</b> <i>Named Event:</i> ANC.B9. Conduct laboratory tests and imaging<br/>
<b>Then:</b>
<table class="grid-dict">
<tr>
<td>
In settings where the proportion of HCV antibody seroprevalence in the general population is 2% or higher, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
<b>If:</b> <i>Applicability:</i> &quot;Population prevalence of hepatitis C&quot; ≥ 2% <i>(Should Conduct hepatitis C test)</i><br/>
</td>
</tr>
<tr>
<td>
If the woman is HIV positive, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing<br/>
<b>If:</b> <i>Applicability:</i> &quot;HIV status&quot; = &quot;HIV positive&quot; <i>(Should Conduct hepatitis C test 2)</i><br/>
</td>
</tr>
<tr>
<td>
If the woman injects drugs, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
<b>If:</b> <i>Applicability:</i> &quot;Current alcohol and/or other substance use&quot; = &quot;Injectable drugs&quot; <i>(Should Conduct hepatitis C test 3)</i><br/>
</td>
</tr>
<tr>
<td>
If a woman is a sex worker, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing.<br/>
<b>If:</b> <i>Applicability:</i> &quot;Occupation&quot; = &quot;Informal employment (sex worker)&quot; <i>(Should Conduct hepatitis C test 4)</i><br/>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
</text>
<url value="http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT10"/>
<identifier>
<use value="official"/>
<value value="ANC.DT.10"/>
</identifier>
<version value="0.3.0"/>
<name value="ANCDT10"/>
<title value="ANC.DT.10 Hepatitis C testing"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
<code value="eca-rule"/>
</coding>
</type>
<status value="active"/>
<experimental value="false"/>
<date value="2021-06-11T23:02:59-06:00"/>
<publisher value="World Health Organization (WHO)"/>
<contact>
<telecom>
<system value="url"/>
<value value="https://www.who.int"/>
</telecom>
</contact>
<description
value="Depending on the population prevalence, and woman's medical history, conduct hepatitis C testing"/>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="task"/>
<display value="Workflow Task"/>
</code>
<valueCodeableConcept>
<coding>
<system
value="http://fhir.org/guides/who/anc-cds/CodeSystem/activity-codes"/>
<code value="ANC.B9."/>
<display value="Conduct laboratory tests and imaging"/>
</coding>
</valueCodeableConcept>
</useContext>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
</coding>
</jurisdiction>
<library value="http://fhir.org/guides/who/anc-cds/Library/ANCDT10"/>
<action>
<title value="ANC.DT.10 Hepatitis C testing"/>
<trigger>
<type value="named-event"/>
<name value="ANC.B9. Conduct laboratory tests and imaging"/>
</trigger>
<action id="1">
<title value="Conduct hepatitis C test"/>
<description value="Conduct hepatitis C test"/>
<textEquivalent
value="In settings where the proportion of HCV antibody seroprevalence in the general population is 2% or higher, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
<documentation>
<type value="citation"/>
<label
value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
</documentation>
<condition>
<kind value="applicability"/>
<expression>
<description
value=""Population prevalence of hepatitis C" ≥ 2%"/>
<language value="text/cql-identifier"/>
<expression value="Should Conduct hepatitis C test"/>
</expression>
</condition>
</action>
<action id="2">
<title value="Conduct hepatitis C test"/>
<description value="Conduct hepatitis C test 2"/>
<textEquivalent
value="If the woman is HIV positive, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing"/>
<documentation>
<type value="citation"/>
<label
value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
</documentation>
<condition>
<kind value="applicability"/>
<expression>
<description
value=""HIV status" = "HIV positive""/>
<language value="text/cql-identifier"/>
<expression value="Should Conduct hepatitis C test 2"/>
</expression>
</condition>
</action>
<action id="3">
<title value="Conduct hepatitis C test"/>
<description value="Conduct hepatitis C test 3"/>
<textEquivalent
value="If the woman injects drugs, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
<documentation>
<type value="citation"/>
<label
value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
</documentation>
<condition>
<kind value="applicability"/>
<expression>
<description
value=""Current alcohol and/or other substance use" = "Injectable drugs""/>
<language value="text/cql-identifier"/>
<expression value="Should Conduct hepatitis C test 3"/>
</expression>
</condition>
</action>
<action id="4">
<title value="Conduct hepatitis C test"/>
<description value="Conduct hepatitis C test 4"/>
<textEquivalent
value="If a woman is a sex worker, then a hepatitis C test is required.
Anti-HCV laboratory-based immunoassay is the preferred method for testing for Hep C infection in pregnancy; if immunoassay is not available, anti-HCV rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) anti-HCV testing."/>
<documentation>
<type value="citation"/>
<label
value="Guidelines on hepatitis B and C testing (2017): Recommendation 6.1 (4)"/>
</documentation>
<condition>
<kind value="applicability"/>
<expression>
<description
value=""Occupation" = "Informal employment (sex worker)""/>
<language value="text/cql-identifier"/>
<expression value="Should Conduct hepatitis C test 4"/>
</expression>
</condition>
</action>
</action>
</PlanDefinition>
IG © 2019+ World Health Organization (WHO). Package who.fhir.anc-cds#0.3.0 based on FHIR 4.0.1. Generated 2024-09-10
Links: Table of Contents |
QA Report
| Version History 
|